| COSMIC: the catalogue of somatic mutations in cancer JG Tate, S Bamford, HC Jubb, Z Sondka, DM Beare, N Bindal, ... Nucleic acids research 47 (D1), D941-D947, 2019 | 3763 | 2019 |
| COSMIC: somatic cancer genetics at high-resolution SA Forbes, D Beare, H Boutselakis, S Bamford, N Bindal, J Tate, CG Cole, ... Nucleic acids research 45 (D1), D777-D783, 2017 | 1987 | 2017 |
| COSMIC: high‐resolution cancer genetics using the catalogue of somatic mutations in cancer SA Forbes, D Beare, N Bindal, S Bamford, S Ward, CG Cole, M Jia, C Kok, ... Current protocols in human genetics 91 (1), 10.11. 1-10.11. 37, 2016 | 883 | 2016 |
| Arpeggio: a web server for calculating and visualising interatomic interactions in protein structures HC Jubb, AP Higueruelo, B Ochoa-Montaño, WR Pitt, DB Ascher, ... Journal of molecular biology 429 (3), 365-371, 2017 | 380 | 2017 |
| Structural biology and drug discovery for protein–protein interactions H Jubb, AP Higueruelo, A Winter, TL Blundell Trends in pharmacological sciences 33 (5), 241-248, 2012 | 202 | 2012 |
| Mutations at protein-protein interfaces: Small changes over big surfaces have large impacts on human health HC Jubb, AP Pandurangan, MA Turner, B Ochoa-Montaño, TL Blundell, ... Progress in biophysics and molecular biology 128, 3-13, 2017 | 156 | 2017 |
| Protein–protein interactions as druggable targets: recent technological advances AP Higueruelo, H Jubb, TL Blundell Current opinion in pharmacology 13 (5), 791-796, 2013 | 149 | 2013 |
| Flexibility and small pockets at protein–protein interfaces: new insights into druggability H Jubb, TL Blundell, DB Ascher Progress in biophysics and molecular biology 119 (1), 2-9, 2015 | 136 | 2015 |
| TIMBAL v2: update of a database holding small molecules modulating protein–protein interactions AP Higueruelo, H Jubb, TL Blundell Database 2013, bat039, 2013 | 89 | 2013 |
| PDBe-KB: a community-driven resource for structural and functional annotations M Varadi, J Berrisford, M Deshpande, SS Nair, A Gutmanas, D Armstrong, ... Nucleic Acids Research 48 (D1), D344-D353, 2020 | 75 | 2020 |
| Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif Q Wu, H Jubb, TL Blundell Progress in biophysics and molecular biology 117 (2-3), 143-148, 2015 | 45 | 2015 |
| COSMIC-3D provides structural perspectives on cancer genetics for drug discovery HC Jubb, HK Saini, ML Verdonk, SA Forbes Nature genetics 50 (9), 1200-1202, 2018 | 36 | 2018 |
| Protein-protein interactions: structures and druggability DB Ascher, HC Jubb, DEV Pires, T Ochi, A Higueruelo, TL Blundell Multifaceted roles of crystallography in modern drug discovery, 141-163, 2015 | 14 | 2015 |
| Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: a preliminary computational analysis of the COSMIC Cancer Gene Census S Malhotra, AF Alsulami, Y Heiyun, BM Ochoa, H Jubb, S Forbes, ... PLoS One 14 (7), e0219935, 2019 | 13 | 2019 |
| COSMIC: Integrating and interpreting the world's knowledge of somatic mutations in cancer Z Sondka, S Bamford, CG Cole, E Dawson, L Ponting, R Stefancsik, ... Cancer Research 78 (13_Supplement), 3284-3284, 2018 | 2 | 2018 |
| COSMIC-3D: exploring cancer mutations in three dimensions for drug design and discovery HC Jubb, H Saini, M Verdonk, S Forbes Cancer Research 77 (13_Supplement), 2601-2601, 2017 | 1 | 2017 |
| Multiprotein assemblies: modulating cell activity through targeting protein-protein interfaces AP HIGUERUELO, H JUBB, TOML BLUNDELL Biomolecular Forms and Functions: A Celebration of 50 Years of the …, 2013 | 1 | 2013 |
| COSMIC-3D: Impacts of cancer mutations on protein structure, function, and druggability HC Jubb, HK Saini, ML Verdonk, SA Forbes Cancer Research 78 (13_Supplement), 3285-3285, 2018 | | 2018 |
| 223 Advances in structure-based drug design Joanna Schaffhausen CW Murray, ML Verdonk, DC Rees, Z Zhu, H Jubb, AP Higueruelo, ... | | |
| Database update TIMBAL v2: update of a database holding small molecules modulating protein–protein interactions AP Higueruelo, H Jubb, TL Blundell | | |
Tom L BlundellEmeritus Professor of Biochemistry, University of CambridgeVerified email at cam.ac.uk
